Literature DB >> 2069800

Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F.

A Giwercman1, L Cantell, A Marks.   

Abstract

In an immunohistochemical study of 59 routinely processed tissue specimens from 48 adult testes with isolated carcinoma-in-situ (CIS) changes and of 66 specimens from adult testes without neoplasia, placental-like alkaline phosphatase (PlAP) was shown to be a reliable marker of CIS cells preceding the development of a testicular tumour. Thus, a positive reaction was encountered in all 36 biopsies treated with formaldehyde, or Bouin's or Stieve's fluid. However, only 11 of 23 specimens fixed with Cleland's fluid were immunoreactive for PlAP. None of the non-malignant components of seminiferous tubules, including the large abnormal spermatogonia, reacted with the antibody against PlAP. Besides the antibody against PlAP, monoclonal antibodies M2A and 43-9F were tested on CIS specimens fixed with the above-mentioned fixatives. In the 17 specimens fixed with Stieve's or Bouin's fluid, a positive reaction was obtained in all sections with all three antibodies tested. However, for each antibody at least two specimens gave a weak staining reaction. When all three immunostainings were performed, in each case at least one of them gave a moderate or strong reaction, thus making CIS cells easily detectable. In the samples fixed with Cleland's fluid, a negative reaction was found in one to three specimens, depending on the antibody used. However, at least one of the three antibodies gave a positive reaction if all three immunostainings were applied. In only one of the formaldehyde-fixed paraffin specimens did CIS cells react with the monoclonal antibody 43-9F, whereas M2A gave no positive reaction at all if this method of fixation was used. Thus, the sensitivity of the immunohistochemical staining procedure in the detection of CIS is dependent on the fixative used and increases when immunostainings with all three markers are performed simultaneously.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069800     DOI: 10.1111/j.1699-0463.1991.tb01231.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

1.  Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours.

Authors:  Si Brask Sonne; Amy S Herlihy; Christina E Hoei-Hansen; John E Nielsen; Kristian Almstrup; Niels E Skakkebaek; Alexander Marks; Henrik Leffers; Ewa Rajpert-De Meyts
Journal:  Virchows Arch       Date:  2006-05-31       Impact factor: 4.064

Review 2.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

3.  Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ.

Authors:  J L Kang; E Rajpert-De Meyts; J Wiels; N E Skakkebaek
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance.

Authors:  E Rajpert-De Meyts; M Kvist; N E Skakkebaek
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

5.  The distribution pattern of cytokeratin and vimentin immunoreactivity in testicular biopsies of infertile men.

Authors:  M Bergmann; S Kliesch
Journal:  Anat Embryol (Berl)       Date:  1994-12

Review 6.  Current concepts of radiation treatment of carcinoma in situ of the testis.

Authors:  A Giwercman; H von der Maase; M Rørth; N E Skakkebaek
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours.

Authors:  A Marks; D R Sutherland; D Bailey; J Iglesias; J Law; M Lei; H Yeger; D Banerjee; R Baumal
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours.

Authors:  K Almstrup; C E Hoei-Hansen; J E Nielsen; U Wirkner; W Ansorge; N E Skakkebaek; E Rajpert-De Meyts; H Leffers
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

9.  Laser capture microdissection of gonads from juvenile zebrafish.

Authors:  Anne Jørgensen; John E Nielsen; Jane E Morthorst; Poul Bjerregaard; Henrik Leffers
Journal:  Reprod Biol Endocrinol       Date:  2009-09-14       Impact factor: 5.211

10.  Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis.

Authors:  D G Kristensen; J E Nielsen; A Jørgensen; N E Skakkebæk; E Rajpert-De Meyts; K Almstrup
Journal:  Br J Cancer       Date:  2013-11-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.